Cross Country Healthcare, Inc. (CCRN)
NASDAQ: CCRN · Real-Time Price · USD
13.10
-0.03 (-0.23%)
May 18, 2026, 4:00 PM EDT - Market closed
Cross Country Healthcare Analyst Ratings
Total Analysts
9
Consensus Rating
Hold
Price Target
$13.53
Upside
+3.28%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Hold Maintains $10 → $13 | Hold | Maintains | $10 → $13 | +1.15% | May 11, 2026 |
| Benchmark | Benchmark | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 8, 2026 |
| Wedbush | Wedbush | Buy → Hold Downgrades $15 → $13 | Buy → Hold | Downgrades | $15 → $13 | +1.15% | May 7, 2026 |
| Wedbush | Wedbush | Hold → Buy Upgrades $11 → $15 | Hold → Buy | Upgrades | $11 → $15 | +14.50% | Mar 19, 2026 |
| Benchmark | Benchmark | Hold → Strong Buy Upgrades $14 | Hold → Strong Buy | Upgrades | $14 | +6.87% | Mar 5, 2026 |
| Wedbush | Wedbush | Hold Initiates $11 | Hold | Initiates | $11 | -16.03% | Feb 3, 2026 |
| UBS | UBS | Hold Maintains $17 → $9 | Hold | Maintains | $17 → $9 | -31.30% | Dec 9, 2025 |
| Barrington Research | Barrington Research | Hold Maintains $19 | Hold | Maintains | $19 | +42.06% | Jun 17, 2025 |
| UBS | UBS | Hold Maintains $19 → $17 | Hold | Maintains | $19 → $17 | +25.95% | May 13, 2025 |
| Barrington Research | Barrington Research | Hold Maintains $19 | Hold | Maintains | $19 | +42.06% | Mar 14, 2025 |
| UBS | UBS | Hold Maintains $14 → $19 | Hold | Maintains | $14 → $19 | +42.06% | Mar 6, 2025 |
| JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Feb 6, 2025 |
| Barrington Research | Barrington Research | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Dec 10, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $15 → $19 | Hold | Maintains | $15 → $19 | +42.06% | Dec 5, 2024 |
| UBS | UBS | Hold Maintains $19 → $14 | Hold | Maintains | $19 → $14 | +6.87% | Nov 8, 2024 |
| Benchmark | Benchmark | Strong Buy Maintains $19 → $18 | Strong Buy | Maintains | $19 → $18 | +37.40% | Nov 7, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.